Skip to NavigationSkip to content

Sanofi axes four major players from its executive committee

Published on 13/02/20 at 01:00pm

Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief Executive Officer Paul Hudson, who joined the company in September last year.

The reshuffle was announced during Sanofi’s fourth-quarter earnings call. The intention is to streamline the committee’s operations and cut down on internal bureaucracy. As Hudson said, the move should help “allocate more of our central expertise into our business units and increase the accountability.”

Following the move, the committee will shrink to 10 members. Those to lose their positions include Ameet Nathwani, Chief Digital and Medical Officer, who joined Sanofi in 2016 before climbing to his current role in 2019, as well as Kathleen Tregoning, Executive Vice President, External Affairs, and Dieter Weinand, Executive Vice President of Primary Care Unit.

Also facing the axe is Dominique Carouge, Executive Vice President, Business Transformation, who has been with the company since 1991, having previous served as Deputy Chief Financial Officer.

Matt Fellows

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches